Literature DB >> 35655813

Uterine leiomyosarcoma diagnosis after treatment of presumed uterine fibroid with the high-intensity focused ultrasound: a case description.

Sha Wang1, Hua Duan1, Xiaoying Zhang1, Bohan Li1.   

Abstract

Entities:  

Year:  2022        PMID： 35655813      PMCID： PMC9131339          DOI： 10.21037/qims-21-814

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN： 2223-4306


× No keyword cloud information.
  15 in total

Review 1.  How to differentiate uterine leiomyosarcoma from leiomyoma with imaging.

Authors:  S Sun; P A Bonaffini; S Nougaret; L Fournier; A Dohan; J Chong; J Smith; H Addley; C Reinhold
Journal:  Diagn Interv Imaging       Date:  2019-08-16       Impact factor: 4.026

2.  Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes.

Authors:  Amrei Binzer-Panchal; Elin Hardell; Anders Isaksson; Joseph W Carlson; Björn Viklund; Mehran Ghaderi; Tjalling Bosse; Marisa R Nucci; Cheng-Han Lee; Nina Hollfelder; Pádraic Corcoran; Jordi Gonzalez-Molina; Lidia Moyano-Galceran; Debra A Bell; John K Schoolmeester; Anna Måsbäck; Gunnar B Kristensen; Ben Davidson; Kaisa Lehti
Journal:  Clin Cancer Res       Date:  2019-01-07       Impact factor: 12.531

Review 3.  Uterine Leiomyosarcoma.

Authors:  Ingolf Juhasz-Böss; Lena Gabriel; Rainer M Bohle; Lars C Horn; Erich-Franz Solomayer; Georg-Peter Breitbach
Journal:  Oncol Res Treat       Date:  2018-10-16       Impact factor: 2.825

Review 4.  Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment?

Authors:  Danielle DeMulder; Susan M Ascher
Journal:  AJR Am J Roentgenol       Date:  2018-10-24       Impact factor: 3.959

5.  Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy.

Authors:  Daniel S Kapp; Jacob Y Shin; John K Chan
Journal:  Cancer       Date:  2008-02-15       Impact factor: 6.860

6.  Contrast-Enhanced Ultrasound Imaging of Uterine Disorders: A Systematic Review.

Authors:  Barbara Stoelinga; Lynda Juffermans; Anniek Dooper; Marleen de Lange; Wouter Hehenkamp; Thierry Van den Bosch; Judith Huirne
Journal:  Ultrason Imaging       Date:  2021-05-26       Impact factor: 1.578

Review 7.  Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.

Authors:  Hideaki Tsuyoshi; Yoshio Yoshida
Journal:  Cancer Sci       Date:  2018-05-23       Impact factor: 6.716

8.  MR guided high intensity focused ultrasound (MRgHIFU) for treating recurrent gynaecological tumours: a pilot feasibility study.

Authors:  Sharon L Giles; Georgios Imseeh; Ian Rivens; Gail R Ter Haar; Alexandra Taylor; Nandita M deSouza
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

Review 9.  The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis.

Authors:  Elizabeth A Pritts; David J Vanness; Jonathan S Berek; William Parker; Ronald Feinberg; Jacqueline Feinberg; David L Olive
Journal:  Gynecol Surg       Date:  2015-05-19

Review 10.  High-intensity focused ultrasound for treatment of recurrent uterine leiomyosarcoma: a case report and literature review.

Authors:  Junyan Li; Xuejun Chen; Xiaoye Hu
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.